A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

Clinical trial NCT07110571 · RECRUITING

Trial details

NCT number: NCT07110571
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal-junction Cancer

Start date: 2025-08-28
Primary completion: 2026-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.